{
    "Trade/Device Name(s)": [
        "Innovacon\u2122 hCG Ultra Test Device"
    ],
    "Submitter Information": "Innovacon Inc",
    "510(k) Number": "K062361",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHI"
    ],
    "Summary Letter Date": "August 11, 2006",
    "Summary Letter Received Date": "August 14, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Rapid chromatographic immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for Innovacon\u2122 hCG Ultra Test Device, a rapid chromatographic immunoassay for qualitative detection of hCG in serum or urine for early pregnancy detection",
    "Indications for Use Summary": "A rapid chromatographic immunoassay for qualitative detection of human chorionic gonadotropin (hCG) in serum or urine to aid in early detection of pregnancy for professional in-vitro diagnostic use only",
    "fda_folder": "Clinical Chemistry"
}